CDH2 and non-small cell lung carcinoma: Positive expression of PD-L1 was noted in 14/30 (46.7%), whereas EMT markers were observed in lower frequencies: Vimentin in 2/30 (6.7%) and N-Cadherin in 4/30 (13.3%) of NSCLC tissues (Table 2).